Glickman Urological & Kidney Institute Outcomes
Surgical Quality Improvement
Nephrectomy Outcomes
Nephrectomy ACS NSQIP Outcomes
January 1, 2023 – December 31, 2023
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s nephrectomy ACS NSQIP performance benchmarked against 126 participating sites.
Nephrectomy (126 Sites) | N | Observed | Expected |
---|---|---|---|
30 Day Mortality | 218 | 0.92% | 0.50% |
30 Day Morbidity | 218 | 8.72% | 10.65% |
Cardiac | 218 | 1.83% | 1.29% |
Pneumonia | 218 | 0.00% | 1.31% |
Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 218 | 0.46% | 0.99% |
Renal Failure | 218 | 3.21% | 3.08% |
Surgical Site Infection (SSI) | 218 | 1.83% | 2.80% |
Sepsis | 217 | 0.46% | 1.28% |
Unplanned Reoperation | 218 | 0.46% | 1.94% |
Length of Stay | 218 | 27.78% | 23.31% |
Unplanned Readmission | 218 | 6.88% | 5.66% |
Rectal Injury | 218 | 0.00% | 0.29% |
Prolonged NPO/NGT Use | 218 | 3.21% | 2.93% |
Ureteral Obstruction | 218 | 0.00% | 0.31% |
Urinary Leak/Fistula | 218 | 1.38% | 0.54% |
Lymphocele/Leak/Fluid | 218 | 0.46% | 1.41% |
American College of Surgeons National Surgical Quality Improvement Program, 2024.
ACS NSQIP® Semiannual Report July 8, 2024, Chicago: American College of Surgeons.